Centro de Investigación Médica Aplicada-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2023

  1. Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in Mammals

    ACS Nano, Vol. 17, Núm. 23, pp. 23331-23346

2022

  1. Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma

    Cancers, Vol. 14, Núm. 21

2020

  1. Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?

    Molecular Therapy - Nucleic Acids, Vol. 21, pp. 192-204

2018

  1. Intratumoral injection of activated B lymphoblast in combination with PD-1 blockade induces systemic antitumor immunity with reduction of local and distal tumors

    OncoImmunology, Vol. 7, Núm. 8

2016

  1. Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy

    Biomaterials, Vol. 91, pp. 73-80